Evidence map›Paper›PMID 27659672›Full record

ArticleDigestive diseases and sciences2016

Age and Prevalence of Esophageal Reflux Disease in Japanese Patients with Type 2 Diabetes Mellitus: The Dogo Study.

Yoshio Ikeda, Shinya Furukawa, Takenori Sakai, Tetsuji Niiya, Hiroaki Miyaoka, Teruki Miyake, Shin Yamamoto, Hidenori Senba, Yasunori Yamamoto, Eiji Arimitsu and 7 more

Abstract read
PubMed Publisher
In one paragraph

Article in Digestive diseases and sciences, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Yoshio IkedaEndoscopy Center, Ehime University Hospital, Shitsukawa, Toon, Ehime, 791-0295, Japan.
Shinya FurukawaDepartment of Epidemiology and Preventive Medicine, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime, 791-0295, Japan. shinya.furukawa@gmail.com.ORCID 0000-0002-0041-7688
Takenori SakaiDepartment of Internal Medicine, Yawatahama General City Hospital, Yawatahama, Ehime, 796-8502, Japan.
Tetsuji NiiyaDepartment of Internal Medicine, Matsuyama Shimin Hospital, Otemachi, Matsuyama, Ehime, 790-0067, Japan.
Hiroaki MiyaokaDepartment of Internal Medicine, Saiseikai Matsuyama Hospital, Yamanishi 880-2, Matsuyama, Ehime, 791-8026, Japan.
Teruki MiyakeDepartment of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime, 791-0295, Japan.
Shin YamamotoDepartment of Lifestyle-related Medicine and Endocrinology, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime, 791-0295, Japan.
Hidenori SenbaDepartment of Epidemiology and Preventive Medicine, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime, 791-0295, Japan.
Yasunori YamamotoEndoscopy Center, Ehime University Hospital, Shitsukawa, Toon, Ehime, 791-0295, Japan.
Eiji ArimitsuDepartment of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime, 791-0295, Japan.
Sen YagiDepartment of Inflammatory Bowel Diseases and Therapeutics, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime, 791-0295, Japan.
Hiroki UtsunomiyaEndoscopy Center, Ehime University Hospital, Shitsukawa, Toon, Ehime, 791-0295, Japan.
Keiko TanakaDepartment of Epidemiology and Preventive Medicine, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime, 791-0295, Japan.
Eiji TakeshitaDepartment of Inflammatory Bowel Diseases and Therapeutics, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime, 791-0295, Japan.
Bunzo MatsuuraDepartment of Lifestyle-related Medicine and Endocrinology, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime, 791-0295, Japan.
Yoshihiro MiyakeDepartment of Epidemiology and Preventive Medicine, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime, 791-0295, Japan.
Yoichi HiasaDepartment of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime, 791-0295, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOnly limited epidemiological evidence exists regarding the relationship between age and gastroesophageal reflux disease (GERD) among Japanese patients with type 2 diabetes mellitus.

aimThe purpose of the present study is to investigate this issue among Japanese patients with type 2 diabetes mellitus.

methodsA multicenter cross-sectional study was conducted in 847 Japanese patients with type 2 diabetes mellitus. Subjects were divided into quartiles according to age: (1) 19 ≤ age < 56, (2) 56 ≤ age < 64, (3) 64 ≤ age < 71, and (4) 71 ≤ age < 89. GERD was defined as present when a subject had a Carlsson-Dent self-administered questionnaire (QUEST) score ≥4.

resultsThe prevalence of GERD was 31.5 %. Younger age was independently associated with a higher prevalence of GERD: the adjusted odds ratios (95 % confidence intervals) for GERD in relation to age < 56, 56 ≤ age < 64, 64 ≤ age < 71, and ≥71 were 3.73 (2.16-6.53), 1.98 (1.21-3.27), 1.66 (1.05-2.68), and 1.00 (reference), respectively (P for trend = 0.001). Among 201 patients with PPI or histamine H

conclusionsYounger age may be independently positively associated with GERD among Japanese type 2 diabetes mellitus patients, regardless of the use of PPI or H2RA.

Indexed as

AdultAgedAged, 80 and overAge DistributionBoron CompoundsCohort StudiesComorbidityCross-Sectional StudiesDiabetes Mellitus, Type 2FemaleGastroesophageal RefluxHistamine H2 AntagonistsHumansJapanMaleMethacrylatesBoron CompoundsHistamine H2 AntagonistsMethacrylatesMethylmethacrylatesProton Pump InhibitorsSuper-bondAgeDiabetesEsophagitisNonerosive reflux diseaseYoung

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.